Journal article

Spironolactone may reduce the risk of incident rosacea.

  • Spoendlin J Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.
  • Voegel JJ Galderma Research and Development, Sophia Antipolis, France.
  • Jick SS Boston Collaborative Drug Surveillance Program, Boston University, Lexington, Massachusetts, USA.
  • Meier CR Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switzerland; Boston Collaborative Drug Surveillance Program, Boston University, Lexington, Massachusetts, USA. Electronic address: christoph.meier@usb.ch.
Show more…
  • 2013-04-19
Published in:
  • The Journal of investigative dermatology. - 2013
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://sonar.ch/global/documents/90238
Statistics

Document views: 52 File downloads:
  • fulltext.pdf: 0